This brand name is authorized in Japan
The drug CALBLOCK contains one active pharmaceutical ingredient (API):
1
Azelnidipine
UNII PV23P19YUG - AZELNIDIPINE
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C08CA | Dihydropyridine derivatives | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2149043F1020, 2149043F2026 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.